Heart failure with preserved ejection fraction in african americans. The ARIC (Atherosclerosis risk in communities) study

JACC: Heart Failure

Volumn 1, Issue 2, 2013, Pages 156-163

  Gupta, Deepak K ^a   Shah, Amil M ^a   Castagno, Davide ^b   Takeuchi, Madoka ^a   Loehr, Laura R ^c   Fox, Ervin R ^d   Butler, Kenneth R ^d   Mosley, Thomas H ^d   Kitzman, Dalane W ^e   Solomon, Scott D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF TURIN   (Italy)

^c IL   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; Echocardiography; Heart failure with preserved ejection fraction; Heart failure with reduced ejection fraction; Mortality

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; SYNDROME DELINEATION;

AFRICAN AMERICANS; AGED; ATHEROSCLEROSIS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE VOLUME;

EID: 84877936429     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.01.003     Document Type: Article

References (56)

1. Bibbins-Domingo K., Pletcher M.J., Lin F., et al. Racial differences in incident heart failure among young adults. N Engl J Med 2009, 360:1179-1190.
2. Bahrami H., Kronmal R., Bluemke D.A., et al. Differences in the incidence of congestive heart failure by ethnicity: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med 2008, 168:2138-2145.
3. Loehr L.R., Rosamond W.D., Chang P.P., Folsom A.R., Chambless L.E. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol 2008, 101:1016-1022.
4. Thomas K.L., Hernandez A.F., Dai D., et al. Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure. Am Heart J 2011, 161:746-754.
5. Kamath S.A., Drazner M.H., Wynne J., Fonarow G.C., Yancy C.W. Characteristics and outcomes in African American patients with decompensated heart failure. Arch Intern Med 2008, 168:1152-1158.
6. Yancy C.W., Abraham W.T., Albert N.M., et al. Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. J Am Coll Cardiol 2008, 51:1675-1684.
7. Martin T.C. Comparison of Afro-Caribbean patients presenting in heart failure with normal versus poor left ventricular systolic function. Am J Cardiol 2007, 100:1271-1273.
8. Hogg K., Swedberg K., McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004, 43:317-327.
9. Dries D.L., Exner D.V., Gersh B.J., Cooper H.A., Carson P.E., Domanski M.J. Racial differences in the outcome of left ventricular dysfunction. N Engl J Med 1999, 340:609-616.
10. Agoston I., Cameron C.S., Yao D., Dela Rosa A., Mann D.L., Deswal A. Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved ejection fraction. Am J Cardiol 2004, 94:1003-1007.
11. East M.A., Peterson E.D., Shaw L.K., Gattis W.A., O'Connor C.M. Racial differences in the outcomes of patients with diastolic heart failure. Am Heart J 2004, 148:151-156.
12. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989, 129:687-702.
13. Skelton T.N., Andrew M.E., Arnett D.K., et al. Echocardiographic left ventricular mass in African-Americans: the Jackson cohort of the Atherosclerosis Risk in Communities study. Echocardiography 2003, 20:111-120.
14. Nunez E., Arnett D.K., Benjamin E.J., et al. Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study. Hypertension 2005, 45:58-63.
15. Redfield M.M., Jacobsen S.J., Burnett J.C., Mahoney D.W., Bailey K.R., Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003, 289:194-202.
16. Wilhelmsen L., Eriksson H., Svardsudd K., Caidahl K. Improving the detection and diagnosis of congestive heart failure. Eur Heart J 1989, 10(Suppl C):13-18.
17. Folsom A.R., Yamagishi K., Hozawa A., Chambless L.E. Absolute and attributable risks of heart failure incidence in relation to optimal risk factors. Circ Heart Fail 2009, 2:11-17.
18. Wong T.Y., Rosamond W., Chang P.P., et al. Retinopathy and risk of congestive heart failure. JAMA 2005, 293:63-69.
19. Kottgen A., Russell S.D., Loehr L.R., et al. Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study. J Am Soc Nephrol 2007, 18:1307-1315.
20. Folsom A.R., Peacock J.M., Boerwinkle E. Variation in PCSK9, low LDL cholesterol, and risk of peripheral arterial disease. Atherosclerosis 2009, 202:211-215.
21. Yancy C.W. Heart failure in African Americans. Am J Cardiol 2005, 96:3i-12i.
22. Franciosa J.A., Ferdinand K.C., Yancy C.W. Treatment of heart failure in African Americans: a consensus statement. Congest Heart Fail 2010, 16:27-38.
23. Taylor A.L., Ziesche S., Yancy C., et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 2004, 351:2049-2057.
24. Magana-Serrano J.A., Almahmeed W., Gomez E., et al. Prevalence of heart failure with preserved ejection fraction in Latin American, Middle Eastern, and North African regions in the I PREFER study (Identification of Patients With Heart Failure and Preserved Systolic Function: an epidemiological regional study). Am J Cardiol 2011, 108:1289-1296.
25. Deswal A., Petersen N.J., Urbauer D.L., Wright S.M., Beyth R. Racial variations in quality of care and outcomes in an ambulatory heart failure cohort. Am Heart J 2006, 152:348-354.
26. Gottdiener J.S., McClelland R.L., Marshall R., et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 2002, 137:631-639.
27. Devereux R.B., Roman M.J., Liu J.E., et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol 2000, 86:1090-1096.
28. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Reiss C.K., Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999, 33:1948-1955.
29. Ilksoy N., Hoffman M., Moore R.H., Easley K., Jacobson T.A. Comparison of African-American patients with systolic heart failure versus preserved ejection fraction. Am J Cardiol 2006, 98:806-808.
30. Kitzman D.W. Diastolic heart failure in the elderly. Heart Fail Rev 2002, 7:17-27.
31. Fox E., Taylor H., Andrew M., et al. Body mass index and blood pressure influences on left ventricular mass and geometry in African Americans: the Atherosclerotic Risk in Communities (ARIC) study. Hypertension 2004, 44:55-60.
32. Lorber R., Gidding S.S., Daviglus M.L., Colangelo L.A., Liu K., Gardin J.M. Influence of systolic blood pressure and body mass index on left ventricular structure in healthy African-American and white young adults: the CARDIA study. J Am Coll Cardiol 2003, 41:955-960.
33. de Simone G., Palmieri V., Bella J.N., et al. Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study. J Hypertens 2002, 20:323-331.
34. Lee M., Gardin J.M., Lynch J.C., et al. Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: the Cardiovascular Health Study. Am Heart J 1997, 133:36-43.
35. Burchfiel C.M., Skelton T.N., Andrew M.E., et al. Metabolic syndrome and echocardiographic left ventricular mass in blacks: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2005, 112:819-827.
36. Astor B.C., Arnett D.K., Brown A., Coresh J. Association of kidney function and hemoglobin with left ventricular morphology among African Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis 2004, 43:836-845.
37. Ather S., Chan W., Bozkurt B., et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 2012, 59:998-1005.
38. Liao Y., Cooper R.S., McGee D.L., Mensah G.A., Ghali J.K. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA 1995, 273:1592-1597.
39. Kamath S., Markham D., Drazner M.H. Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of heart failure follow?. Heart Fail Rev 2006, 11:271-277.
40. Gordon H.S., Nowlin P.R., Maynard D., Berbaum M.L., Deswal A. Mortality after hospitalization for heart failure in blacks compared to whites. Am J Cardiol 2010, 105:694-700.
41. Thomas K.L., East M.A., Velazquez E.J., et al. Outcomes by race and etiology of patients with left ventricular systolic dysfunction. Am J Cardiol 2005, 96:956-963.
42. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 2012, 33:1750-1757. Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC).
43. Solomon S.D., Anavekar N., Skali H., et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005, 112:3738-3744.
44. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355:251-259.
45. Bhatia R.S., Tu J.V., Lee D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355:260-269.
46. Lee D.S., Gona P., Vasan R.S., et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute. Circulation 2009, 119:3070-3077.
47. Packer M. Can brain natriuretic peptide be used to guide the management of patients with heart failure and a preserved ejection fraction? The wrong way to identify new treatments for a nonexistent disease. Circ Heart Fail 2011, 4:538-540.
48. Campbell R.T., Jhund P.S., Castagno D., Hawkins N.M., Petrie M.C., McMurray J.J. What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-Preserved, and I-PRESERVE?. J Am Coll Cardiol 2012, 60:2349-2356.
49. Lee D.S., Gona P., Albano I., et al. A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction. Circ Heart Fail 2011, 4:36-43.
50. Zile M.R., Gaasch W.H., Anand I.S., et al. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-PRESERVE) trial. Circulation 2010, 121:1393-1405.
51. Henkel D.M., Redfield M.M., Weston S.A., Gerber Y., Roger V.L. Death in heart failure: a community perspective. Circ Heart Fail 2008, 1:91-97.
52. Kitzman D.W. Outcomes in patients with heart failure with preserved ejection fraction: it is more than the heart. J Am Coll Cardiol 2012, 59:1006-1007.
53. Shah S.J., Gheorghiade M. Heart failure with preserved ejection fraction: treat now by treating comorbidities. JAMA 2008, 300:431-433.
54. Avery C.L., Mills K.T., Chambless L.E., et al. Long-term association between self-reported signs and symptoms and heart failure hospitalizations: the Atherosclerosis Risk In Communities (ARIC) study. Eur J Heart Fail 2010, 12:232-238.
55. Hunt S.A., Abraham W.T., Chin M.H., et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009, 53:e1-e90.
56. Gandhi S.K., Powers J.C., Nomeir A.M., et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001, 344:17-22.